Abstract:Xin Zhao, 1, 2, &ast Yue Ge, 1, 3, &ast Yuan Zhang, 1 WenJie Zhang, 1 HongBin Hu, 1 LuLan Li, 1 Tong Sha, 1 ZhenHua Zeng, 1 Feng Wu, 1 ZhongQing Chen 1 1 Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China; 2 The First Clinical Medical School, Southern Medical University, Guangzhou, People's Republic of China; 3 Department of School of Nursing, Southern Medical University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: ZhongQing Chen; Feng Wu, Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China, Tel +86 13503049103 ; +86 15915751705, Email ; Background: Next-generation sequencing of the metagenome (mNGS) is increasingly used in pathogen diagnosis for infectious diseases due to its short detection time. The time for Oxford Nanopore Technologies (ONT) sequencing-based etiology detection is further shortened compared with that of mNGS, but only a few studies have verified the time advantage and accuracy of ONT sequencing for etiology diagnosis. In 2022, a study confirmed that there was no significant difference in sensitivity and specificity between ONT and mNGS in suspected community-acquired pneumonia patients, which there was no clinical study verified in patients with SHAP. Methods: From October 24 to November 20, 2022, 10 patients with severe hospital-acquired pneumonia (SHAP) in the Nanfang Hospital intensive care unit (ICU) were prospectively enrolled. Bronchoalveolar lavage fluid (BALF) was collected for ONT sequencing, mNGS, and traditional culture. The differences in pathogen detection time and diagnostic agreement among ONT sequencing, mNGS, traditional culture method, and clinical composite diagnosis were compared. Results: Compared with mNGS and the traditional culture method, ONT sequencing had a significant advantage in pathogen detection time (9.6± 0.7 h versus 24.7± 2.7 h versus 132± 58 h, P < 0.05). The agreement rate between ONT sequencing and the clinical composite diagnosis was 73.3% (kappa value=0.737, P < 0.05). Conclusion: ONT sequencing has a potential advantage for rapidly identifying pathogens. Keywords: Oxford Nanopore Technologies, Nanopore sequencing, metagenomic next-generation sequencing, severe hospital-acquired pneumonia, pathogen Severe hospital-acquired pneumonia (SHAP) is the most common acquired infection in the intensive care unit (ICU) and one of the main causes of increased mortality in ICU patients. 1,2 Potential multidrug-resistant pathogens are very common in ICU-acquired pneumonia, including Pseudomonas aeruginosa, Acinetobacter spp., methicillin-resistant Staphylococcus aureus (MRSA), and ultrabroad spectrum β-lactamase (ESBL)-producing and carbapenem-resistant Enterobacteriaceae (CRE). 3 Timely and appropriate antibiotic treatment is effective in reducing patient mortality, but it often takes up to 48 hours from respiratory sampling to the acquisition of definitive microbiological test results, which leads to untimely antibiotic therapy and increased mortality. 3 Therefore, early identification of the pathogen and timely use of targeted antibiotics is particularly important to improve prognosis. The traditional culture of bronchoscopy specimens remains the gold standard of pathogenic detection. However, the turnaround time of bacterial/fungal cultures is long (3–7 days) in conventional microbiological testing. 4 The low positive rates cannot meet the need for early pathogen diagnosis. 5 mNGS, known as a powerful, low-cost, shorter turn round-time method, has been used in pathogen diagnosis in recent years. The turnaround time of mNGS is usually 24–36 hours, and the positive rate is 15% higher than that of culture. 6 Several studies have shown that the diagnostic accuracy of mNGS was not inferior to traditional culture (61.7% vs 76.7%, P=0.11), and the 28-day mortality of the mNGS group was significantly lower than culture group (47.32% vs 62.2%, P=0.043) due to its shorter pathogen detection time. 7,8 Nevertheless, each step of mNGS requires sequence restriction to short 200–500 bp read lengths, and these shorter read lengths make genome, transcriptome, and metagenome assembly more challenging. 9 Third-generation sequencing, also known as Nanopore sequencing, uses a long-read length assay to compensate for the shortcomings of mNGS. 10 The turnaround time of Nanopore sequencing is on -Abstract Truncated-

Third-Generation Sequencing in the Clinical Laboratory: Exploring the Advantages and Challenges of Nanopore Sequencing

High-Throughput Metagenomics for Identification of Pathogens in the Clinical Settings

An evolution of Nanopore next-generation sequencing technology: implications for medical microbiology and public health

An Introduction to Nanopore Sequencing: Past, Present, and Future Considerations

NanoCore: core-genome-based bacterial genomic surveillance and outbreak detection in healthcare facilities from Nanopore and Illumina data

Evaluating metagenomics and targeted approaches for diagnosis and surveillance of viruses

Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing

Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario

Third generation sequencing technologies applied to diagnostic microbiology: benefits and challenges in applications and data analysis

Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis

Applications of Nanopore sequencing in precision cancer medicine

Targeting RNA with Next‐ and Third‐Generation Sequencing Improves Pathogen Identification in Clinical Samples

The application of long-read sequencing in clinical settings

Evaluation of Oxford Nanopore’s MinION Sequencing Device for Microbial Whole Genome Sequencing Applications

Oxford Nanopore's 2024 sequencing technology for outbreak detection and source attribution: progress and clone-specific challenges

A long road/read to rapid high-resolution HLA typing: The nanopore perspective

Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory

Early insights into the potential of the Oxford Nanopore MinION for the detection of antimicrobial resistance genes

An integrated method for targeted Oxford Nanopore sequencing and automated bioinformatics for the simultaneous detection of bacteria, fungi, and ARG

Pathogen Diagnosis Value of Nanopore Sequencing in Severe Hospital-Acquired Pneumonia Patients

Nanopore-Based Metagenomic Sequencing in Respiratory Tract Infection: A Developing Diagnostic Platform